SHELTON CAPITAL MANAGEMENT - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$8,339
-68.9%
11,8640.0%0.00%
-100.0%
Q4 2022$26,813
-29.4%
11,8640.0%0.00%
+50.0%
Q3 2022$38,000
-15.6%
11,8640.0%0.00%0.0%
Q2 2022$45,000
-29.7%
11,8640.0%0.00%0.0%
Q1 2022$64,000
-53.6%
11,864
+15.7%
0.00%
-60.0%
Q4 2021$138,000
-25.0%
10,2500.0%0.01%
-28.6%
Q3 2021$184,000
+4.5%
10,2500.0%0.01%0.0%
Q2 2021$176,000
-14.1%
10,2500.0%0.01%0.0%
Q1 2021$205,000
+17.8%
10,2500.0%0.01%
-12.5%
Q4 2020$174,000
+2.4%
10,2500.0%0.01%
+14.3%
Q3 2020$170,000
-28.3%
10,2500.0%0.01%
-46.2%
Q2 2020$237,000
+23.4%
10,250
-4.5%
0.01%
-7.1%
Q1 2020$192,000
-23.2%
10,730
-7.4%
0.01%0.0%
Q4 2019$250,000
-70.0%
11,587
-17.0%
0.01%
-73.6%
Q4 2017$833,000
+148.7%
13,9520.0%0.05%
+130.4%
Q3 2017$335,000
+12.0%
13,952
-8.7%
0.02%
+9.5%
Q2 2017$299,000
-6.3%
15,283
+12.5%
0.02%
-4.5%
Q1 2017$319,000
+132.8%
13,587
+21.4%
0.02%
+120.0%
Q4 2016$137,000
-28.6%
11,1950.0%0.01%
-37.5%
Q3 2016$192,000
+20.8%
11,1950.0%0.02%
+14.3%
Q2 2016$159,000
+3.2%
11,1950.0%0.01%0.0%
Q1 2016$154,000
-9.9%
11,195
+10.2%
0.01%
-17.6%
Q4 2015$171,000
+54.1%
10,1600.0%0.02%
+41.7%
Q3 2015$111,00010,1600.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders